Construction and biological characteristic for the recombinant modified vaccinia virus ankara co-expressing modified GP5 and M protein of porcine reproductive and respiratory syndrome virus.
- Author:
Qisheng ZHENG
1
;
Peng LI
;
Ruibing CAO
;
Jibo HOU
;
Puyan CHEN
Author Information
1. College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Cell Line;
Genetic Vectors;
genetics;
Porcine Reproductive and Respiratory Syndrome;
prevention & control;
Porcine respiratory and reproductive syndrome virus;
genetics;
Recombinant Fusion Proteins;
biosynthesis;
genetics;
immunology;
Recombination, Genetic;
Swine;
Transfection;
Vaccines, DNA;
genetics;
immunology;
Vaccinia virus;
classification;
genetics;
metabolism;
Viral Envelope Proteins;
biosynthesis;
genetics;
Viral Matrix Proteins;
biosynthesis;
genetics
- From:
Chinese Journal of Biotechnology
2008;24(5):766-773
- CountryChina
- Language:Chinese
-
Abstract:
Modified ORF5 (MORF5) and ORF6 gene of PRRSV were cloned into two multiple cloning sites of MVA transfer vector pLR-gpt to construct the recombinant plasmid pLR-MORF5/ORF6. Homologous recombination between pLR-MORF5/ORF6 and the wtMVA on BHK-21 cell line was mediated with liposome by infecting the cell with 0.01 MOI wtMVA two hours before transfecting the recombinant plasmid into the cell. When the cytopathic effect (CPE) was obvious, virus was collected from the cell plate and the recombinant virus was selected with drug selecting medium (2% MXHAT). After 12 cycles of selection, rMVA with a selection marker Eco gpt was obtained and named as rMVAgpt-MGP5/M. By infecting BHK-Cre expressing Cre recombinant enzyme, the Eco gpt marker in rMVAgpt-MGP5/M was deleted and this rMVA was named as rMVA-MGP5/M. The insertion of MORF5 and ORF6 into the MVA genome was confirmed with PCR analysis and the expression of MGP5 and M protein was identified with Western blot and IFA. Through biological study on the recombinant MVA, no obvious difference was observed between rMVA-MGP5/M and the wtMVA regarding to the CPE and growth curve. The recombinant MVA constructed in this study could coexpress the modified GP5 and M protein and the expressed product had good immunocompetence. Furthermore, the insertion of the MORF5 and ORF6 into MVA genome had no obvious effect on the replication and biological characteristics of this virus.
